Connecting Research and Experts with Journalists

• share
• favorite_border

An aggressive campaign to reduce the unnecessary use of antibiotics has helped cut the rate of infection with a dangerous drug-resistant bacteria at The Valley Hospital in Ridgewood, NJ, by nearly 40 percent.

• share
• favorite_border

Valley Health System, headquartered in Ridgewood, NJ, is proud to have been selected by the Cleveland Clinic Heart & Vascular Institute - the No. 1 heart hospital in the country - to be a regional cardiovascular affiliate.

• share
• favorite_border

The Valley Hospital in Ridgewood, NJ, is one of 15 U.S. sites currently enrolling patients in a research study to evaluate a potential new treatment alternative for patients with symptomatic persistent and long standing persistent atrial fibrillation (AFib).

• share
• favorite_border

The Valley Hospital participated in a landmark clinical trial that evaluated the ability of a novel, fully absorbable antibacterial envelope – the Medtronic TYRX™ Absorbable Antibacterial Envelope – to reduce infections associated with cardiac implantable electronic devices (CIEDs). The study found positive results and demonstrated that the envelope reduced the risk of major infection by 40 percent, and pocket infection by 61 percent, in patients at increased risk for infections receiving CIEDs, compared to standard-of-care pre-operative antibiotics.